Prospectively Collected Pleural Biopsies for Validation of Malignant Pleural Mesothelioma Prognostic Biomarkers

Launched by DANA-FARBER CANCER INSTITUTE · Sep 24, 2018

Keywords

ClinConnect Summary

This clinical trial is looking at a new way to help doctors understand how severe malignant pleural mesothelioma is in patients and what their likely outcomes might be. The study will use samples taken from the chest area during procedures like biopsies or surgeries to gather information that could improve the way doctors assess the disease.

To participate, you need to be an adult (18 years or older) who has been diagnosed with malignant pleural mesothelioma and is scheduled for one of the specific procedures mentioned, like a biopsy or surgery. Unfortunately, if you are not suitable for surgery or treatment, you would not be eligible to join. If you decide to participate, you will contribute to important research that could lead to better diagnosis and treatment options for others with this condition. The trial is currently recruiting participants, so this is a great opportunity to get involved in advancing medical knowledge.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • All adult patients with a diagnosis of malignant pleural mesothelioma undergoing
• • diagnostic pleural biopsy
• • pleuroscopy
• • and/or VATS resections
• • Participants must be 18 years of age or older.
• Exclusion Criteria:
• • -Any patient who is found to be unsuitable for
• • surgery,
• • treatment
• • diagnosis,